M2Bio Sciences (OTC: $WUHN) CEO, Jeff Robinson, is laying out the company’s priority goals for…
CBD
M2Bio Sciences (OTC: $WUHN) CEO, Jeff Robinson, recaps 2020 and shares updates on name changes,…
M2Bio Sciences (OTC: $WUHN) ends the year with a US$450,000 private placement deal and thereby…
Welcome to the 134th edition of The Weekly Bull Report. 2020 has been challenging, but…
The bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research, M2Bio Sciences, is…